Binds GH receptors throughout body. Directly promotes IGF-1 production in liver, stimulates protein synthesis, lipolysis, and bone mineralization.
Studies have administered: 0.01–0.04mg/kg/day studied; varies significantly by indication in trials
Decades of FDA-approved clinical data across growth hormone deficiency, muscle wasting, and Prader-Willi syndrome. Extensive body composition and aging research literature.
Edema, carpal tunnel, joint pain, insulin resistance, IGF-1 elevation with theoretical long-term risks documented in studies
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on HGH 191AA — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat